Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)-Reference-Cited by-同舟云学术

Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)

Published:1983-04 Issue:8 Volume:145 Page:955-967
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Cohen Carmel J.,Goldberg Judith D.,Holland James F.,Bruckner Howard W.,Deppe Gunter,Gusberg Saul B.,Wallach Robert C.,Kabakow Bernard,Rodin John

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference19 articles.

1. Chemotherapy of ovarian cancer: Past and present;Young;Semin, Oncol.,1975

2. Management of ovarian carcinoma: Current concepts and future prospects;Tobias;N. Engl. J. Med.,1976

3. Management of ovarian carcinoma: Current concepts and future prospects;Tobias;N. Engl. J. Med.,1976

4. The role of chemotherapy in the treatment of gynecologic malignancy;Masterson;Am. J. Obstet. Gynecol.,1965

5. Chemotherapy in the treatment of cancer of the ovary;Smith;Am. J. Obstet. Gynecol.,1970

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoreductive surgery;Surgery for Ovarian Cancer;2010-10-15

2. Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate;Cochrane Database of Systematic Reviews;2008-07-16

3. Cisplatin beim Ovarialkarzinom: wieviel und wie lange?;DMW - Deutsche Medizinische Wochenschrift;2008-03-25

4. Outcomes of patients who participate in randomised controlled trials compared to similar patients receiving similar interventions who do not participate;Cochrane Database of Systematic Reviews;2007-04-18

5. The second-look operation improves survival in suboptimally debulked stage III ovarian cancer patients;International Journal of Gynecological Cancer;2005-01